ClinicalTrials.Veeva

Menu

Online COgnitive Behavioural Therapy for Sleep and Mental Health for Older Adults With Insomnia and Subjective Cognitive Complaints (e-COSMOS)

U

University Institute of Geriatrics of Montreal (IUGM)

Status

Enrolling

Conditions

Insomnia

Treatments

Behavioral: education about healthy nutrition habits and communication in older age
Behavioral: cognitive behavioral therapy for sleep, anxiety, and depression

Study type

Interventional

Funder types

Other

Identifiers

NCT06032377
BH210177

Details and patient eligibility

About

The goal of this randomized controlled clinical trial is to assess a novel cognitive-behavioral program for sleep and mental health using a multidomain web platform (eCBTi+) in participants with insomnia and subjective cognitive complaint. The main questions it aims to answer are:

  • Whether the eCBTi+ intervention improves sleep (subjective: Insomnia severity index [ISI], objective: EEG-based sleep efficiency) sleep and mental health (Geriatric Anxiety Index [GAI] and Geriatric Depression Scale [GDS]) compared to the control intervention
  • Whether the eCBTi+ intervention improves cognitive abilities (subjective: Cognitive Failure Questionnaire [CFQ], objective: CANTAB executive functions composite score) compared to the control intervention

Full description

Participants with insomnia disorder will complete:

  • A phone interview
  • Two video conferences (assessment of eligibility and tutorial to set up sleep monitoring devices)
  • 9 nights of at-home polysomnography with an EEG headband (3 times x 3 nights)
  • 42 sleep diaries (3 times x 14 days)
  • 42 days wearing an actigraphy device (3 times x 14 days)
  • Online questionnaires
  • Phone call for a check-in with a psychologist
  • 3 cognitive testing sessions
  • 10 modules of online information on health, over the course of 10 weeks
  • In MRI subgroup: 2 in-person testing

Good sleeper participants will complete:

  • A phone interview
  • Two video conferences (assessment of eligibility and tutorial to set up sleep monitoring devices)
  • 3 nights of at-home polysomnography with an EEG headband
  • 14 sleep diaries
  • 14 days wearing an actigraphy device
  • Online questionnaires
  • 1 cognitive testing session
  • 1 in person session for MRI.

In addition, researchers will compare outcomes from participants with insomnia and subjective cognitive complaint to a group of good sleepers to have normative values for imaging data.

Enrollment

275 estimated patients

Sex

All

Ages

60 to 99 years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion

  • age 60 years or older at the time of enrolment
  • Sleep Condition Indicator, SCI ≤ 16 and/or meeting DSM-V criteria based on the symptoms assessed by the SCI
  • subjective cognitive complaints (self-report version of Everyday Cognition scale (ECog), score ≥ 2 on any item)
  • ability to read and understand French or English
  • ability to use a smartphone or tablet, and access to home internet connection
  • If on hypnotic or psychotropic medication (including cannabis), being on stable dosage for at least 2 months prior to study entry
  • Score on the STOP-BANG questionnaire < 3 corresponding to participants with low risk of obstructive sleep apnea

Exclusion

  • located outside of Québec or Ontario
  • current hospitalization or planned major surgery
  • uncorrected severe hearing or vision impairment
  • reported diagnosis of major neurocognitive disorder or mild cognitive impairment (MCI)
  • performance suggestive of major neurocognitive disorder or MCI on T-MoCA < 17
  • reported diagnosis of schizophrenia or bipolar disorder
  • reported diagnosis or positive screen on the MINI for psychotic or bipolar disorders
  • high suicidal risk, as assessed by the modified Columbia-Suicide Severity Rating Scale
  • reported diagnosis or positive screening (apnea-hypopnea index >30 on a level 3 home sleep apnea test) for another untreated sleep disorder (e.g., sleep disordered breathing (OSA), REM sleep behavior disorder (RBD), restless legs syndrome (RLS); individuals with treated and controlled OSA (residual apnea-hypopnea index <30 and good therapeutic compliance) or RLS will not be excluded
  • current shift work
  • currently receiving CBT, having received CBTi in the past
  • frequent alcohol consumption having an impact on functionning (>10 glasses/week and having a significant impact on functionning)
  • illicit drugs use (more than once a month)

Additional exclusion criteria for neuroimaging

  • psychotropic (including hypnotic) medication in the past 2 weeks
  • contraindications for MRI (e.g., pacemaker, metallic implant, claustrophobia)
  • unable or unwilling to come to one of the participating MRI centers (Montreal, Ottawa)
  • medical conditions likely to affect sleep; in particular:
  • current neurological disorder (e.g., epilepsy with any seizure in the past year, concussion in the past 3 months, multiple sclerosis, Parkinson's disease)
  • past history of brain lesion (e.g., brain hemorrhage, brain tumor, any condition having required brain surgery)
  • major surgery (i.e., requiring general anesthesia) in the past 3 months
  • untreated thyroid disorder
  • chronic pain syndrome self-reported as interfering with sleep (e.g., migraine, fibromyalgia, rheumatoid arthritis)
  • recent and severe infection in the past 3 months (e.g., pneumonia, kidney infection)
  • active cancer or treated cancer with post-cancer treatment for less than 2 years

Inclusion/exclusion criteria for good sleepers Twenty-five good sleepers without cognitive complaint will be recruited as controls for the MRI session following the same criteria described above, except that SCI ≥ 17, not meeting the diagnostic criteria for chronic insomnia as assessed by the insomnia module of the SCID and no subjective cognitive complaint.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

275 participants in 2 patient groups

online cognitive behavioral therapy for insomnia, anxiety and depression
Experimental group
Description:
10 self-directed modules of cognitive behavioral therapy for insomnia, anxiety and depression, delivered online, once a week
Treatment:
Behavioral: cognitive behavioral therapy for sleep, anxiety, and depression
online intervention on nutrition and communication in older age
Active Comparator group
Description:
10 self-directed modules on healthy nutrition habits and communication strategies, delivered online, once a week
Treatment:
Behavioral: education about healthy nutrition habits and communication in older age

Trial contacts and locations

2

Loading...

Central trial contact

Rebecca Robillard, PhD; Thien Thanh Dang-Vu, MD PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems